Latest Ibritumomab tiuxetan Stories

2008-09-22 12:00:38

Cell Therapeutics has announced that following a meeting with the FDA data from the first-line indolent trial would be sufficient to support a submission for a supplemental biologics license application.

2008-09-22 03:00:12

SEATTLE, Sept. 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) announced today that following a meeting with the U.S.

2008-09-17 12:00:35

InNexus Biotechnology, a drug development company, has announced the results of an extensive mouse tumor study demonstrating superiority of the company's DXL625 compared to Rituxan in the xenograft model.

2008-09-02 09:00:43

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the appointment of Patrick O'Connor, PhD, Vice President, Research, Michael J.

2008-08-21 09:01:14

SOUTH SAN FRANCISCO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. announced today that Christine A. White, M.D. has been appointed to the company's board of directors.

2008-08-05 03:00:11

SEATTLE, Aug. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company") (Nasdaq: CTIC; MTA) t announced that Craig W. Philips has assumed his role as CTI's new President, and will concentrate on managing the company's drug development and commercial operations.

2008-07-28 18:00:00

THE TOBACCO plant - responsible for millions of cancer cases - may actually offer the means to treat one form of the disease, a study says. US scientists used the plant to "grow" key components of a cancer vaccine.

2008-07-22 03:00:18

SEATTLE, July 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Company has scheduled a meeting with the U.S.

2008-07-18 09:01:12

Biovest, a subsidiary of Accentia, has announced positive data from a pivotal trial of BiovaxID in lymphoma, and the vaccine now stands a good chance of becoming the first therapeutic cancer vaccine to gain approval in the seven major markets.

2008-07-15 21:00:30

SEATTLE, July 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.

Word of the Day
  • To say in too many words; to express verbosely.
  • To express in too many words: sometimes used reflexively.
  • The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.
The word 'overword' comes from over- +‎ word.